Viewing Study NCT00233350


Ignite Creation Date: 2025-12-24 @ 5:07 PM
Ignite Modification Date: 2026-01-06 @ 8:49 AM
Study NCT ID: NCT00233350
Status: COMPLETED
Last Update Posted: 2015-10-01
First Post: 2005-10-04
Is Gene Therapy: True
Has Adverse Events: False

Brief Title: Clinical Evaluation of Navigated 3D Ultrasound Multicentre Study
Sponsor: Norwegian University of Science and Technology
Organization:

Study Overview

Official Title: Clinical Evaluation of Navigated 3D Ultrasound Multicentre Study
Status: COMPLETED
Status Verified Date: 2012-10
Last Known Status: None
Delayed Posting: No
If Stopped, Why?: Not Stopped
Has Expanded Access: False
If Expanded Access, NCT#: N/A
Has Expanded Access, NCT# Status: N/A
Acronym: None
Brief Summary: 3D ultrasound is a new modality used in image guided neurosurgery. a multicentre study is started for the evaluation of this tool as a means for achieving total resection of brain tumors at greater safety.
Detailed Description: The degree of resection as judged by the surgeon is recorded at the end of surgery for each patient, and then compared with the postoperative MRI. Neurological status before and after surgery, QOL before surgery and at follow-up as well as survival is recorded.

Study Oversight

Has Oversight DMC: False
Is a FDA Regulated Drug?: None
Is a FDA Regulated Device?: None
Is an Unapproved Device?: None
Is a PPSD?: None
Is a US Export?: None
Is an FDA AA801 Violation?: